Monica Gandhi, MD, MPH

Headshot of Monica Gandhi
User Profile Photo

Monica Gandhi, MD, MPH

User Profile Name
Director, UCSF-Bay Area CFAR
Professor, School of Medicine
User Profile Title
User Profile Email

Biography

Dr. Gandhi has been at UCSF since 1996 when she came here for her medical residency after attending Harvard Medical School. She completed an ID fellowship at UCSF from 1999-2003 and a Masters’ in Public Health in Epidemiology/Biostatistics from the University of California, Berkeley in 2001, as well as a Traineeship in AIDS Prevention Studies (TAPS) post-doctoral fellowship. She has been an NIH funded researcher since 2003, first with a K23 award and now with multiple R01 and R21 grants to help run the UCSF Hair Analytical Laboratory (HAL), a laboratory that focuses on objective adherence metrics to HIV treatment and prevention for multiple UCSF-based and global investigators in hair and urine. She served on the Office of AIDS Research Advisory Committee (OARAC) from 2014-2017 and Chair from 2017-2018. She also serves on the ACTG Executive Committee. She has served as the co-director of the CFAR Mentoring Program for the past five years and has a dedicated interest in HIV mentorship and education.

Dr. Gandhi serves as the Medical Director of the Ward 86 HIV Clinic (since January 2014) and won the HIV Medical Association (HIVMA) Clinical Educator Award in 2017 and was awarded the Master Clinician award in the Department of Medicine in 2019. Beyond an interest in adherence metrics and PrEP, Dr. Gandhi has a special interest in HIV and women and sex differences in HIV medicine. She is thrilled to serve in this role to support the HIV/AIDS researcher community across UCSF and our many affiliates. She is especially interested in mentoring early stage investigators, especially those from underrepresented racial/ethnic minorities, from disadvantaged backgrounds, and with disabilities. Monica plans an open door policy with the CFAR community here at UCSF and is excited to serve with you all in continuing to make UCSF an innovative and exciting place to conduct HIV research.

User Profile Bio

Displaying 176 - 200 of 291

  1. Greene M, Hessol NA, Perissinotto C, Zepf R, Hutton Parrott A, Foreman C, Whirry R, Gandhi M, John M. Loneliness in Older Adults Living with HIV. AIDS Behav. 2018 05; 22(5):1475-1484.
  2. Sauceda JA, Neilands TB, Johnson MO, Saberi P. An update on the Barriers to Adherence and a Definition of Self-Report Non-adherence Given Advancements in Antiretroviral Therapy (ART). AIDS Behav. 2018 03; 22(3):939-947.
  3. Baxi SM, Vittinghoff E, Bacchetti P, Huang Y, Chillag K, Wiegand R, Anderson PL, Grant R, Greenblatt RM, Buchbinder S, Gandhi M, Liu AY. Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial. PLoS One. 2018; 13(1):e0190118.
  4. Saberi P, Berrean B, Thomas S, Gandhi M, Scott H. A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study. JMIR Form Res. 2018 Jan-Jun; 2(1).
  5. Cohn SE, Chappell C, Gandhi M. . Human Immunodeficiency Virus in Women. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2018.
  6. Seifert SM, Castillo-Mancilla JR, Erlandson K, Morrow M, Gandhi M, Kuncze K, Horng H, Zheng JH, Bushman LR, Kiser JJ, MaWhinney S, Anderson PL. Brief Report: Adherence Biomarker Measurements in Older and Younger HIV-Infected Adults Receiving Tenofovir-Based Therapy. J Acquir Immune Defic Syndr. 2018 03 01; 77(3):295-298.
  7. Roh ME, Shiboski S, Natureeba P, Kakuru A, Muhindo M, Ochieng T, Plenty A, Koss CA, Clark TD, Awori P, Nakalambe M, Cohan D, Jagannathan P, Gosling R, Havlir DV, Kamya MR, Dorsey G. Protective Effect of Indoor Residual Spraying of Insecticide on Preterm Birth Among Pregnant Women With HIV Infection in Uganda: A Secondary Data Analysis. J Infect Dis. 2017 12 19; 216(12):1541-1549.
  8. Markowitz M, Grossman H, Anderson PL, Grant R, Gandhi M, Horng H, Mohri H. Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):e104-e106.
  9. Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M. Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States. Clin Infect Dis. 2018 01 06; 66(2):213-219.
  10. McNicholl IR, Gandhi M, Hare CB, Greene M, Pierluissi E. A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients. Pharmacotherapy. 2017 12; 37(12):1498-1506.
  11. Mave V, Kinikar A, Kagal A, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Gerona R, Wen A, Ramachandran G, Kumar H, Bacchetti P, Dooley KE, Gupte N, Gupta A, Gandhi M. Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis. PLoS One. 2017; 12(12):e0189101.
  12. Gandhi M, Murnane PM, Bacchetti P, Elion R, Kolber MA, Cohen SE, Horng H, Louie A, Kuncze K, Koss CA, Anderson PL, Buchbinder S, Liu A. Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen. AIDS. 2017 Oct 23; 31(16):2245-2251.
  13. Markowitz M, Grossman H, Anderson PL, Grant R, Gandhi M, Horng H, Mohri H. Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):e104-e106.
  14. Martin Markowitz, Howard Grossman, Peter L. Anderson, Robert Grant, Monica Gandhi, Howard Horng, Hiroshi Mohri. Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2017 Dec 1; 76(4):e104-e106.
  15. Saberi P, Neilands TB, Ming K, Johnson MO, Kuncze K, Koss CA, Gandhi M. Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):e101-e103.
  16. McNicholl IR, Gandhi M, Hare CB, Greene M, Pierluissi E. A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients. Pharmacotherapy. 2017 12; 37(12):1498-1506.
  17. Braun HM, Segura ER, Lake JE, Gandhi M, Rios J, Villaran MV, Sanchez J, Lama JR, Clark JL. Individual and partnership factors associated with anticipated versus actual partner notification following STI diagnosis among men who have sex with men and/or with transgender women in Lima, Peru. Sex Transm Infect. 2018 12; 94(8):607-610.
  18. Christopoulos KA, Hartogensis W, Glidden DV, Pilcher CD, Gandhi M, Geng EH. Limitations of using the Lorenz curve framework to understand the distribution of population viral load: authors' reply. AIDS. 2017 03 13; 31(5):742-743.
  19. Koss CA, Bacchetti P, Hillier SL, Livant E, Horng H, Mgodi N, Mirembe BG, Gomez Feliciano K, Horn S, Liu AY, Glidden DV, Grant RM, Benet LZ, Louie A, van der Straten A, Chirenje ZM, Marrazzo JM, Gandhi M. Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. AIDS Res Hum Retroviruses. 2017 08; 33(8):778-783.
  20. Christopoulos KA, Hartogensis W, Glidden DV, Pilcher CD, Gandhi M, Geng EH. The Lorenz curve: a novel method for understanding viral load distribution at the population level. AIDS. 2017 01 14; 31(2):309-310.
  21. Zachary Tabb, Blandina Mmbaga, Monica Gandhi, Alexander Louie, Karen Kuncze, Aisa Shayo, Elizabeth Turner, Coleen Cunningham, Dorothy Dow. Association of Self-Reported Adherence and Antiretroviral Drug Concentrations in Hair Among Youth with Virologic Failure in Tanzania. Open Forum Infectious Diseases. 2017 Jan 1; 4(suppl_1):s663-s664.
  22. Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, Calderon F, Demicco E, Geng E, Gandhi M, Havlir DV, Hatano H. The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting. J Acquir Immune Defic Syndr. 2017 Jan 01; 74(1):44-51.
  23. Shari L. Dworkin, Monica Gandhi, Paige Passano. Women's Empowerment and Global Health: A Twenty-First-Century Agenda. 2016.
  24. Gustafson DR, Shi Q, Holman S, Minkoff H, Cohen MH, Plankey MW, Havlik R, Sharma A, Gange S, Gandhi M, Milam J, Hoover DR. Predicting death over 8 years in a prospective cohort of HIV-infected women: the Women's Interagency HIV Study. BMJ Open. 2017 06 30; 7(6):e013993.
  25. Gandhi M, Glidden DV, Mayer K, Schechter M, Buchbinder S, Grinsztejn B, Hosek S, Casapia M, Guanira J, Bekker LG, Louie A, Horng H, Benet LZ, Liu A, Grant RM. Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study. Lancet HIV. 2016 11; 3(11):e521-e528.